192 related articles for article (PubMed ID: 8676424)
1. Allogeneic fibroblasts used to grow cultured epidermal autografts persist in vivo and sensitize the graft recipient for accelerated second-set rejection.
Hultman CS; Brinson GM; Siltharm S; deSerres S; Cairns BA; Peterson HD; Meyer AA
J Trauma; 1996 Jul; 41(1):51-8; discussion 58-60. PubMed ID: 8676424
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of cultured keratinocyte allografts deficient in major histocompatibility complex antigens.
Hultman CS; Hunt JP; Yamamoto H; Giannopoulos A; deSerres S; Frelinger JA; Meyer AA
J Trauma; 1998 Jul; 45(1):25-33; discussion 33-4. PubMed ID: 9680007
[TBL] [Abstract][Full Text] [Related]
3. Cultured mouse keratinocyte allografts prime for accelerated second set rejection and enhanced cytotoxic lymphocyte response.
Cairns BA; deSerres S; Matsui M; Frelinger JA; Meyer AA
Transplantation; 1994 Jul; 58(1):67-72. PubMed ID: 8036710
[TBL] [Abstract][Full Text] [Related]
4. Xenogeneic mouse fibroblasts persist in human cultured epidermal grafts: a possible mechanism of graft loss.
Cairns BA; deSerres S; Brady LA; Hultman CS; Meyer AA
J Trauma; 1995 Jul; 39(1):75-9; discussion 79-80. PubMed ID: 7636913
[TBL] [Abstract][Full Text] [Related]
5. Prolonged survival of cultured keratinocyte allografts in the nonimmunosuppressed mouse.
Hammond EJ; Ng RL; Stanley MA; Munro AJ
Transplantation; 1987 Jul; 44(1):106-12. PubMed ID: 3299909
[TBL] [Abstract][Full Text] [Related]
6. Host priming, not target antigen type, decides rejection rate in mice primed with MHC II "knockout" cultured keratinocytes.
Hunt JP; Hunter CT; Brownstein M; Hultman CS; deSerres S; Bracey L; Frelinger J; Meyer AA
J Surg Res; 1998 Apr; 76(1):32-6. PubMed ID: 9695735
[TBL] [Abstract][Full Text] [Related]
7. Burn injury impairs second-set rejection and CTL reactivity in mice primed by cultured keratinocyte allografts.
Hultman CS; Cairns BA; deSerres S; Frelinger JA; Meyer AA
Transplantation; 1995 Sep; 60(6):584-9. PubMed ID: 7570955
[TBL] [Abstract][Full Text] [Related]
8. Dissociation of antigenicity and immunogenicity of neonatal epidermal allografts in the mouse.
Demidem A; Chiller JM; Kanagawa O
Transplantation; 1990 May; 49(5):966-71. PubMed ID: 2336712
[TBL] [Abstract][Full Text] [Related]
9. Rejection, after a slightly prolonged survival time, of Langerhans cell-free allogeneic cultured epidermis used for wound coverage in humans.
Auböck J; Irschick E; Romani N; Kompatscher P; Höpfl R; Herold M; Schuler G; Bauer M; Huber C; Fritsch P
Transplantation; 1988 Apr; 45(4):730-7. PubMed ID: 3258682
[TBL] [Abstract][Full Text] [Related]
10. The 1995 Moyer Award. The effect of burn injury on allograft rejection, alloantigen processing, and cytotoxic T-lymphocyte sensitization.
Hultman CS; Cairns BA; Yamamoto H; deSerres S; Frelinger JA; Meyer AA
J Burn Care Rehabil; 1995; 16(6):573-80. PubMed ID: 8582933
[TBL] [Abstract][Full Text] [Related]
11. Evidence that epidermal alloantigen Epa-1 is an immunogen for murine heart as well as skin allograft rejection.
Steinmuller D; Wakely E; Landas SK
Transplantation; 1991 Feb; 51(2):459-63. PubMed ID: 1994543
[TBL] [Abstract][Full Text] [Related]
12. Prolonged skin grafts survival time by IFN-γ in allogeneic skin transplantation model during acute rejection through IFN-γ/STAT3/IDO pathway in epidermal layer.
Zhang Y; Wang Y; Wu G; Zhang W; Wang X; Cai W; Zhang J; Han S; Li Y; Bai X; Shi J; Su L; Hu D
Biochem Biophys Res Commun; 2018 Feb; 496(2):436-442. PubMed ID: 29288671
[TBL] [Abstract][Full Text] [Related]
13. The role of allogeneic epidermis in murine graft rejection.
Lerner-Tung MB; Hull BE
J Burn Care Rehabil; 1989; 10(2):151-5. PubMed ID: 2651451
[TBL] [Abstract][Full Text] [Related]
14. Cultured keratinocyte grafts are recognized, but not rejected by CD8+ T cells in vivo.
Tinois E; Cobbold S; Faure M; Yeoman H; Stanley M
Eur J Immunol; 1989 Jun; 19(6):1031-5. PubMed ID: 2473908
[TBL] [Abstract][Full Text] [Related]
15. Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia- epidermal cells.
Rosenberg AS; Katz SI; Singer A
J Immunol; 1989 Oct; 143(8):2452-6. PubMed ID: 2477443
[TBL] [Abstract][Full Text] [Related]
16. Rejection of cultured keratinocyte allografts in presensitized mice.
Kawai K; Ikarashi Y; Tomiyama K; Matsumoto Y; Fujiwara M
Transplantation; 1993 Aug; 56(2):265-9. PubMed ID: 8356578
[TBL] [Abstract][Full Text] [Related]
17. Immune tolerance of tissue-engineered skin produced with allogeneic or xenogeneic fibroblasts and syngeneic keratinocytes grafted on mice.
Goyer B; Larouche D; Kim DH; Veillette N; Pruneau V; Bernier V; Auger FA; Germain L
Acta Biomater; 2019 May; 90():192-204. PubMed ID: 30953802
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic versus xenogeneic immune reaction to bioengineered skin grafts.
Erdag G; Morgan JR
Cell Transplant; 2004; 13(6):701-12. PubMed ID: 15648740
[TBL] [Abstract][Full Text] [Related]
19. Cultured keratinocyte allografts fail to induce sensitization in vivo.
Cairns BA; deSerres S; Kilpatrick K; Frelinger JA; Meyer AA
Surgery; 1993 Aug; 114(2):416-22. PubMed ID: 8342143
[TBL] [Abstract][Full Text] [Related]
20. In vitro production and transplantation of immunologically active skin equivalents.
Rouabhia M
Lab Invest; 1996 Oct; 75(4):503-17. PubMed ID: 8874382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
